Pentixapharm Holding AG Stock
A loss of -2.120% shows a downward development for Pentixapharm Holding AG.
Pros and Cons of Pentixapharm Holding AG in the next few years
Pros
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
News
EQS-News: Pentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program
EQS-News: Pentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program
EQS-News: Pentixapharm Completes Capital Increase – New Shares Placed in Full
EQS-News: Pentixapharm Completes Capital Increase – New Shares Placed in Full
EQS-Adhoc: Pentixapharm Holding AG completes rights offering and private placement with significant oversubscription generating gross proceeds of approx. EUR 20.4 Million already today
EQS-Adhoc: Pentixapharm Holding AG completes rights offering and private placement with significant oversubscription generating gross proceeds of approx. EUR 20.4 Million already today